FCER2 and nasopharyngeal carcinoma: In a nasopharyngeal carcinoma study, it was found that FCER2 was a downregulated gene in nasopharyngeal carcinoma, and its expression levels were significantly lower in nasopharyngeal carcinoma than in adjacent tissues.